BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38626148)

  • 1. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
    Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
    Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study.
    Chornenki NLJ; Siegal DM; Qamar K; Woolgar S; Rangarajan S; Karampatos S; Leong DP; Hillis CM
    Leuk Res; 2022 Feb; 113():106788. PubMed ID: 35042128
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocytosis and MPNs: Where do we stand?
    Coltoff A
    Leuk Lymphoma; 2023 Mar; 64(3):564-572. PubMed ID: 36519233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real world data on myeloproliferative neoplasms in Japan].
    Edahiro Y
    Rinsho Ketsueki; 2022; 63(9):1083-1091. PubMed ID: 36198533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
    Edahiro Y; Ochiai T; Hashimoto Y; Ichii M; Okatani T; Omura H; Nakajima K; Sasaki M; Ando J; Takaku T; Koike M; Izumiyama K; Hiraga J; Yano T; Usuki K; Ohtsuka E; Yokoyama K; Oyake T; Takahashi N; Nishida T; Nakao T; Fukuda Y; Akasaka T; Mugitani A; Ando M; Komatsu N
    Hematology; 2024 Dec; 29(1):2340149. PubMed ID: 38626148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities.
    Coltro G; Loscocco GG; Vannucchi AM
    Int Rev Cell Mol Biol; 2021; 365():1-69. PubMed ID: 34756241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera.
    Khodier M; Gadó K
    Physiol Int; 2023 Sep; 110(3):227-250. PubMed ID: 37651280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions.
    Goulart H; Mascarenhas J; Tremblay D
    Ann Hematol; 2022 May; 101(5):935-951. PubMed ID: 35344066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Myeloproliferative Neoplasms.
    El-Sharkawy F; Margolskee E
    Clin Lab Med; 2021 Sep; 41(3):529-540. PubMed ID: 34304780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bomedemstat as an investigative treatment for myeloproliferative neoplasms.
    Rienhoff HY; Gill H
    Expert Opin Investig Drugs; 2023; 32(10):879-886. PubMed ID: 37804041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
    Shallis RM; Zeidan AM; Wang R; Podoltsev NA
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):177-189. PubMed ID: 33641862
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.